Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
About this item
Full title
Author / Creator
Zhang, Fengwen , Jenkins, Jesse , de Carvalho, Renan V. H. , Nakandakari-Higa, Sandra , Chen, Teresia , Abernathy, Morgan E. , Baharani, Viren A. , Nyakatura, Elisabeth K. , Andrew, David , Lebedeva, Irina V. , Lorenz, Ivo C. , Hoffmann, H.-Heinrich , Rice, Charles M. , Victora, Gabriel D. , Barnes, Christopher O. , Hatziioannou, Theodora and Bieniasz, Paul D.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Human monoclonal antibodies (mAbs) that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been isolated from convalescent individuals and developed into therapeutics for SARS-CoV-2 infection. However, therapeutic mAbs for SARS-CoV-2 have been rendered obsolete by the emergence of mAb-resistant virus variants...
Alternative Titles
Full title
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
Authors, Artists and Contributors
Author / Creator
Jenkins, Jesse
de Carvalho, Renan V. H.
Nakandakari-Higa, Sandra
Chen, Teresia
Abernathy, Morgan E.
Baharani, Viren A.
Nyakatura, Elisabeth K.
Andrew, David
Lebedeva, Irina V.
Lorenz, Ivo C.
Hoffmann, H.-Heinrich
Rice, Charles M.
Victora, Gabriel D.
Barnes, Christopher O.
Hatziioannou, Theodora
Bieniasz, Paul D.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10234812
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10234812
Other Identifiers
ISSN
2058-5276
E-ISSN
2058-5276
DOI
10.1038/s41564-023-01389-9
